Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
24m agoGalderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
24m agoSurface Transforms plc – in Administration, Sale of Business and Assets
25m agoGuerbet: Changes to the Composition of Guerbet’s Board of Directors.
25m agoRENAULT S.A. : disclosure of trading in own shares from May 15 to May 20, 2026
26m agoAssystem: Combined General Meeting of 22 May 2026 - Voting Results and dividend for financial year 2025
Neurotech International Ltd. logo

Neurotech International Ltd.

About

0.01AUD+0.00 +0.00%
Closed • Updated at 17:00 GMT+00:00
Market Cap$11.29M
Volume319.1K
Beta0.68
RSI49.43
Health TechnologyMedical Specialties

Neurotech International Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 17 2026
NTI initiates First Clinical Site for Phase 3 ASD Trial
Feb 26 2026
Appendix 4D & Half Year Report
Feb 23 2026
Positive 90-day GLP toxicology study results in non-rodents
Feb 2 2026
Approval received for NTI164 Phase 3 Clinical Study in ASD
Jan 30 2026
Quarterly Activities/Appendix 4C Cash Flow Report

Community Chat

Ask AI

6ix6ixAIEvents